With the increasing number of individuals with diabetes and obesity, nonalcoholic fatty liver
disease (NAFLD) is becoming increasingly prevalent, affecting one-quarter of adults …

The metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that identify
patients at increased risk of diabetes type 2 and cardiovascular disease. 1 These factors …

Non-alcoholic fatty liver disease (NAFLD) stands as an increasingly pressing global health
challenge, underscoring the need for timely identification to facilitate effective treatment and …

Abstract Background & Aim: Hepatic endothelial cells release ferritin in response to
increased oxidative stress and lipid peroxidation. The principal aim of this study was to …

Hepatic steatosis is characterized by the accumulation of lipid droplets in the liver. Although
relatively benign, simple steatosis can eventually lead to the development of steatohepatitis …

: Non-alcoholic steatohepatitis (NASH), first described by Ludwig et al, in 1980, is a stage in
the wide spectrum of non-alcoholic fatty liver diseases (NAFLDs) and one of the leading …

酒精性脂肪性肝病与非酒精性脂肪性肝病的血液生化学检查特点 主页 简体中文 English 简体中文
登录 BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化 …

Introduction. Clinical, epidemiological and biochemical studies strongly support the concept
that the non-alcoholic fatty liver disease is a hepatic manifestation of the metabolic …

Background: Non-alcoholic fatty liver disease (NAFLD) is one of most important cause of
fatty liver that may lead to endstage liver disease. Various studies have reported that serum …

With the increasing number of individuals with diabetes and obesity, nonalcoholic fatty liver
disease (NAFLD) is becoming increasingly prevalent, affecting one-quarter of adults …